Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Immunovant, Inc. | 1,178,191 | reported | 16 Apr 2025 | tx 58+6,664,645−1,541,772 |
| Corbus Pharmaceuticals Holdings, Inc. | 2,783 | reported | 30 May 2024 | tx 8+313,966 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 16 Apr 2025 | SALE | Immunovant, Inc. | 8,321 | 14.89 USD | |
| 09 Apr 2025 | SALE | Immunovant, Inc. | 28,094 | 12.99 USD | |
| 01 Apr 2025 | GRANT_AWARD | Immunovant, Inc. | 265,820 | 0.00 USD | |
| 01 Apr 2025 | GRANT_AWARD | Immunovant, Inc. | 374,395 | 0.00 USD | deriv |
| 19 Feb 2025 | SALE | Immunovant, Inc. | 15,439 | 20.86 USD | |
| 15 Jan 2025 | SALE | Immunovant, Inc. | 415 | 24.19 USD | |
| 15 Jan 2025 | SALE | Immunovant, Inc. | 8,352 | 23.81 USD | |
| 08 Jan 2025 | SALE | Immunovant, Inc. | 5,105 | 24.10 USD | |
| 20 Nov 2024 | SALE | Immunovant, Inc. | 16,692 | 25.45 USD | |
| 16 Oct 2024 | SALE | Immunovant, Inc. | 9,095 | 28.79 USD | |
| 09 Oct 2024 | SALE | Immunovant, Inc. | 4,460 | 29.56 USD | |
| 21 Aug 2024 | SALE | Immunovant, Inc. | 14,470 | 31.84 USD | |
| 21 Aug 2024 | SALE | Immunovant, Inc. | 598 | 32.32 USD | |
| 17 Jul 2024 | SALE | Immunovant, Inc. | 510 | 30.55 USD | |
| 17 Jul 2024 | SALE | Immunovant, Inc. | 8,175 | 29.64 USD | |
| 09 Jul 2024 | SALE | Immunovant, Inc. | 4,619 | 28.06 USD | |
| 30 May 2024 | GRANT_AWARD | Corbus Pharmaceuticals Holdings, Inc. | 2,783 | 0.00 USD | |
| 22 May 2024 | SALE | Immunovant, Inc. | 16,163 | 29.65 USD | |
| 16 May 2024 | GRANT_AWARD | Corbus Pharmaceuticals Holdings, Inc. | 2,783 | 0.00 USD | deriv |
| 17 Apr 2024 | SALE | Immunovant, Inc. | 7,714 | 29.94 USD | |
| 17 Apr 2024 | SALE | Immunovant, Inc. | 26,365 | 28.80 USD | |
| 09 Apr 2024 | SALE | Immunovant, Inc. | 4,807 | 31.18 USD | |
| 02 Apr 2024 | GRANT_AWARD | Immunovant, Inc. | 160,534 | 0.00 USD | |
| 02 Apr 2024 | GRANT_AWARD | Immunovant, Inc. | 200,667 | 0.00 USD | deriv |
| 22 Feb 2024 | SALE | Immunovant, Inc. | 13,454 | 36.15 USD |